To the Editor: In our earlier assessment of the etiologic role of human bocavirus 1 (HBoV1) among 109 constitutionally healthy children, seroconversion measured by a standard IgG enzyme immunoassay (EIA) was the prime marker of acute infection, and signs and symptoms during sampling intervals were interpreted from hand-written questionnaires and study nurse notes (1) . In that study, we found that acute HBoV1 infection was associated with upper respiratory tract illness (URTI) and acute otitis media. However, after discovery of 3 new human bocaviruses (HBoV2-4), we used a competitive second-generation IgG EIA to differentiate between typespecific and cross-reacting IgG responses and reassessed the etiologic associations of each virus in the same pediatric cohort. We found only a weak correlation of HBoV1 infection with acute otitis media and no correlation with URTI (2).
There are 2 reasons for this discrepancy. First, the competitive second-generation EIA generated a different set of HBoV1-infected children. A total of 27 children initially interpreted as having HBoV1 seroconversions had, on reassessment, HBoV2 or HBoV3 seroconversions (2) . Second, after improved reevaluation of clinical symptoms of the entire replenished cohort by 3 of the co-authors, we found that URTI symptoms of 38 children were classified differently. Despite tight sampling, intervals of 3 and 6 months might still have been too long for clinical assessment for young children with numerous respiratory infections per year. The authors regret any inconvenience to readers.
